MGNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MGNX Shares Outstanding History and MGNX YTD Return |
MGNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MGNX Shares Outstanding History and MGNX YTD Return |
MGNX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+7.24% CAGR Mouse over chart for data details
|
MGNX Stock Price Chart |
About MacroGenics, Inc |
MacroGenics is a biopharmaceutical company. Co.'s main pipeline program is vobramitamab duocarmazine, an antibody-drug conjugate that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Co. is also developing molecules that target programmed cell death protein 1 (PD-1), a protein that is important in the regulation of the immune system's response to cancer. In addition, Co. is developing MGD024, a bispecific DART molecule that engages CD3 on immune effector cells to kill CD123-expressing cancer cells in certain hematological malignancies, including acute myeloid leukemia. We show 44 historical shares outstanding datapoints in our MGNX shares outstanding history coverage, used to compute MGNX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MGNX market cap history over the course of time is important for investors interested in comparing MGNX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MGNX versus a peer is one thing; comparing MGNX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MGNX can fluctuate over the course of history. With this page we aim to empower investors researching MGNX by allowing them to research the MGNX market cap history. |
MGNX Current Stock Quote |
Free MGNX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MGNX Share Performance |
Market Cap Peers |
MacroGenics (MGNX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MGRM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.